BChE-IN-25 (compound 4I) is a selective BChE inhibitor (IC50: 3.77μM), which is 22 times more selective for BChE than AChE[1].
References
[1] Montazer MN, et al. Design, synthesis, and biological studies of the new cysteine-N-arylacetamide derivatives as a potent urease inhibitor. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):305-315. DOI:10.1007/s00210-023-02596-1
